Global Antimicrobial Susceptibility Test Market Outlook (2019 to 2027) - Featuring Biotron Healthcare, Conda & Creative Diagnostics Among Others -

DUBLIN--()--The "Antimicrobial Susceptibility Test - Global Market Outlook (2019-2027)" report has been added to's offering.

The Global Antimicrobial Susceptibility Test market accounted for $2.79 billion in 2019 and is expected to reach $4.98 billion by 2027 growing at a CAGR of 7.5% during the forecast period.

The rising prevalence of infectious diseases and the emergence of multidrug resistance due to drug abuse are the major factors propelling market growth. However, high cost and unfavourable reimbursement scenario are hampering market growth.

Antimicrobial susceptibility testing is a procedure, which is used to determine for a specific organism or group of organisms that are susceptible to an antibiotic. To examine the antimicrobial susceptibility, the most widely used testing methods are broth microdilution or rapid automated instrument methods. These methods are commercially used and marketed with materials and devices. Antimicrobial resistance is developed due to inaccurate diagnosis of infectious disease, lack of effective treatment guidelines, and non-adherence to the treatment regime. Primary healthcare centres of both developed and developing nations are teeming grounds for superbug infection. Microbiologists are working diligently to understand the disease etiology about the antimicrobial confrontation and develop broad-spectrum antibiotics to treat microbial infections.

Based on the application, the clinical diagnostics segment is going to have a lucrative growth during the forecast period owing to factors such as the rising burden of antimicrobial resistance, the increasing prevalence of infectious diseases, and growing awareness about the use of antimicrobial susceptibility testing methods for diagnostic applications. These are the factors that are responsible for the large market share of this application segment.

By geography, North America is going to have a lucrative growth during the forecast period due to the easy accessibility and better adoption of technologically advanced susceptibility testing methods and products. The rising prevalence of antimicrobial resistance in North America is another key factor supporting the expansion of this regional segment in the global antimicrobial susceptibility testing market.

Companies Mentioned

  • Accelerate
  • Alifax Holding S.p.A.
  • Beckman Coulter
  • Becton, Dickinson and Company
  • Bioanalyse
  • Bio-Rad Laboratories
  • Biotron Healthcare
  • Conda
  • Creative Diagnostics
  • Danaher Corporation (Cepheid)
  • HiMedia Laboratories
  • Liofilchem
  • Merck
  • Merlin
  • Synbiosis
  • Thermo Fisher Scientific

What the report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2018, 2019 2020, 2024, and 2027
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company Profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Key Topics Covered:

1 Executive Summary

2 Preface

2.1 Abstract

2.2 Stake Holders

2.3 Research Scope

2.4 Research Methodology

2.4.1 Data Mining

2.4.2 Data Analysis

2.4.3 Data Validation

2.4.4 Research Approach

2.5 Research Sources

2.5.1 Primary Research Sources

2.5.2 Secondary Research Sources

2.5.3 Assumptions

3 Market Trend Analysis

3.1 Introduction

3.2 Drivers

3.3 Restraints

3.4 Opportunities

3.5 Threats

3.6 Product Analysis

3.7 Application Analysis

3.8 End User Analysis

3.9 Emerging Markets

3.10 Impact of Covid-19

4 Porters Five Force Analysis

4.1 Bargaining power of suppliers

4.2 Bargaining power of buyers

4.3 Threat of substitutes

4.4 Threat of new entrants

4.5 Competitive rivalry

5 Global Antimicrobial Susceptibility Test Market, By Product

5.1 Introduction

5.2 Automated Laboratory Instruments

5.3 Consumables

5.4 Culture and Growth Media

5.5 Culture Media

5.6 Manual Testing Products

5.6.1 Mic Strips

5.6.2 Susceptibility Plates

5.6.3 Susceptibility Testing Disks

5.7 Tests and Kits

6 Global Antimicrobial Susceptibility Test Market, By Method

6.1 Introduction

6.2 Automated AST

6.3 Broth Dilution

6.4 Dilution

6.5 Disk Diffusion

6.6 Etest

6.7 Genotypic

6.8 Gradient Diffusion

6.9 Molecular Testing

6.10 Rapid Automated

7 Global Antimicrobial Susceptibility Test Market, By Testing Type

7.1 Introduction

7.2 Antibacterial

7.3 Antifungal

7.4 Antiparasitic

7.5 Viruses and Fastidious Organism Testing

8 Global Antimicrobial Susceptibility Test Market, By Application

8.1 Introduction

8.2 Bioterrorism Surveillance

8.3 Clinical Diagnostics

8.4 Drug Discovery and Development

8.5 Environmental Monitoring

8.6 Epidemiology

8.7 Veterinary Diagnostics

9 Global Antimicrobial Susceptibility Test Market, By End User

9.1 Introduction

9.2 Contract Research Organizations

9.3 Diagnostic Laboratories and Hospitals

9.4 Pharmaceutical and Biotechnology Companies

9.5 Research and Academic Institutes

10 Global Antimicrobial Susceptibility Test Market, By Geography

10.1 Introduction

10.2 North America

10.3 Europe

10.4 Asia Pacific

10.5 South America

10.6 Middle East & Africa

11 Key Developments

11.1 Agreements, Partnerships, Collaborations and Joint Ventures

11.2 Acquisitions & Mergers

11.3 New Product Launch

11.4 Expansions

11.5 Other Key Strategies

12 Company Profiling

For more information about this report visit

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900